James Osei-Owusu

James Osei-Owusu

Auto-generated profile, based on publicly available information

James Osei-Owusu

Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
JYJunhua Yang
Junhua Yang
JCJianan Chen
Jianan Chen
MVMaria del Carmen Vitery
Maria del Carmen Vitery
JOJames Osei-Owusu
James Osei-Owusu
JCJiachen Chu
Jiachen Chu
ZQZhaozhu Qiu
Zhaozhu Qiu
A new protein channel family: Exposure of cells to acidic conditions outside the cell activates chloride-conducting channels that influence physiological and pathological processes. Yang et al. used an unbiased RNA interference screen to identify the channel protein that allows such proton-activated ion conductance. The protein, called PAC for proton-activated channel, has two predicted transmembrane domains and is unlike any previously identified channel. Identification of the channel should advance studies of its physiological roles, which range from tissue injury after stroke to adaptation of Tibetan natives to a high-altitude environment. Science , this issue p. 395

25 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JOJames Osei-Owusu
James Osei-Owusu
EKEkaterina Kots
Ekaterina Kots
ZRZheng Ruan
Zheng Ruan
LMLjubica Mihaljević
Ljubica Mihaljević
KCKevin Hong Chen
Kevin Hong Chen
ZQZhaozhu Qiu
Zhaozhu Qiu
In response to acidic pH, the widely expressed proton-activated chloride (PAC) channel opens and conducts anions across cellular membranes. By doing so, PAC plays an important role in both cellular physiology (endosome acidification) and diseases associated with tissue acidosis (acid-induced cell death). Despite the available structural information, how proton binding in the extracellular domain (ECD) leads to PAC channel opening remains largely unknown. Here, through comprehensive mutagenesis and electrophysiological studies, we identified several critical titratable residues, including two histidine residues (H130 and H131) and an aspartic acid residue (D269) at the distal end of the ECD, together with the previously characterized H98 at the transmembrane domain–ECD interface, as potential pH sensors for human PAC. Mutations of these residues resulted in significant changes in pH sensitivity. Some combined mutants also exhibited large basal PAC channel activities at neutral pH. By combining molecular dynamics simulations with structural and functional analysis, we further found that the β12 strand at the intersubunit interface and the associated “joint region” connecting the upper and lower ECDs allosterically regulate the proton-dependent PAC activation. Our studies suggest a distinct pH-sensing and gating mechanism of this new family of ion channels sensitive to acidic environment.

20 April 2023 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
SESarah C. Erlandson
Sarah C. Erlandson
SRShaun Rawson
Shaun Rawson
JOJames Osei-Owusu
James Osei-Owusu
KBKelly P. Brock
Kelly P. Brock
XLXinyue Liu
Xinyue Liu
AKAndrew C. Kruse
Andrew C. Kruse

22 December 2022 in eLife
Verified
Journal Article
Open access
JOJames Osei-Owusu
James Osei-Owusu
ZRZheng Ruan
Zheng Ruan
LMLjubica Mihaljević
Ljubica Mihaljević
DMDaniel S Matasic
Daniel S Matasic
KCKevin Hong Chen
Kevin Hong Chen
ZQZhaozhu Qiu
Zhaozhu Qiu
Desensitization is a common property of membrane receptors, including ion channels. The newly identified proton-activated chloride (PAC) channel plays an important role in regulating the pH and size of organelles in the endocytic pathway, and is also involved in acid-induced cell death. However, how the PAC channel desensitizes is largely unknown. Here, we show by patch-clamp electrophysiological studies that PAC (also known as TMEM206/ASOR) undergoes pH-dependent desensitization upon prolonged acid exposure. Through structure-guided and comprehensive mutagenesis, we identified several residues critical for PAC desensitization, including histidine (H) 98, glutamic acid (E) 94, and aspartic acid (D) 91 at the extracellular extension of the transmembrane helix 1 (TM1), as well as E107, D109, and E250 at the extracellular domain (ECD)–transmembrane domain (TMD) interface. Structural analysis and molecular dynamic simulations revealed extensive interactions between residues at the TM1 extension and those at the ECD–TMD interface. These interactions likely facilitate PAC desensitization by stabilizing the desensitized conformation of TM1, which undergoes a characteristic rotational movement from the resting and activated states to the desensitized state. Our studies establish a new paradigm of channel desensitization in this ubiquitously expressed ion channel and pave the way for future investigation of its relevance in cellular physiology and disease.

30 September 2026 in Nature
Verified
Journal Article
Open access
PDF file
KRKaitlin Rhee
Kaitlin Rhee
LSLawrence Shue
Lawrence Shue
AAAkimasa Adachi
Akimasa Adachi
PSPengwei Sun
Pengwei Sun
JOJames Osei-Owusu
James Osei-Owusu
XZXin Zhou
Xin Zhou
G-protein-coupled receptors (GPCRs) represent one of the most important yet incompletely addressed classes of therapeutic targets1. Here we report a strategy for functional GPCR antagonism through bispecific antibody-mediated endocytosis and lysosomal degradation. GPCR–TfR1 targeting chimeras (GTACs) achieve potent and selective downregulation of multiple GPCRs, including BILF1, RXFP1 and CCR6—viral, cancer and immune targets that have been difficult to drug2,3,4. GTACs lead to complete inhibition of receptor signalling, including constitutive signalling, with more than one to two orders of magnitude greater potency than conventional antibody antagonists. Using protein engineering and multicolour live-cell imaging, we establish a context-dependent degrader design and explain the cellular mechanisms, with broad relevance for degrader technology. The GTAC platform establishes induced endocytosis and rewiring protein trafficking as a model for therapeutic GPCR modulation.

12 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SPSteffanie Paul
Steffanie Paul
EHEdward P. Harvey
Edward P. Harvey
JOJames Osei-Owusu
James Osei-Owusu
AKAaron W. Kollasch
Aaron W. Kollasch
ARAdam J. Riesselman
Adam J. Riesselman
AKAndrew C. Kruse
Andrew C. Kruse
Antibodies can bind their targets with exquisite potency and selectivity due in part to large antibody-target protein-protein interaction surface areas. Despite the very large size and diversity of synthetic libraries, in vitro sorting alone tends to yield binders with modest affinities. By analogy to the in vivo affinity maturation in the natural immune system, these initial hits are typically affinity matured in vitro to achieve high affinity binding. However, affinity maturation campaigns can be laborious, often requiring multiple selection rounds and strategies for each clone to be optimized. Here, we investigated whether one could accelerate the discovery of optimized binders using machine learning on sequencing data from single selection sorts of affinity maturation yeast-display campaigns. Our results show that sparse sequencing data from a single sorting round can predict sequences that are enriched after multiple rounds. We also find that linear models outperform deep neural networks and semi-supervised approaches in ranking validated affinity-enhancing substitutions. Linear models are also more interpretable, offering insights into residue preferences that can be leveraged for further engineering. We use our models to design and select optimized nanobody binders to relaxin family peptide receptor 1 (RXFP1), yielding multiple improved binders including 3 sub nanomolar binders with the best exhibiting a ∼2500-fold improvement over WT.